Suppr超能文献

淀粉样前体蛋白40(Abeta40)和淀粉样前体蛋白42(Abeta42)的单体形式与聚集形式的比例是β淀粉样蛋白聚集、纤维形成和毒性的重要决定因素。

The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.

作者信息

Jan Asad, Gokce Ozgun, Luthi-Carter Ruth, Lashuel Hilal A

机构信息

Laboratory of Molecular Neurobiology and Neuroproteomics, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.

出版信息

J Biol Chem. 2008 Oct 17;283(42):28176-89. doi: 10.1074/jbc.M803159200. Epub 2008 Aug 11.

Abstract

Aggregation and fibril formation of amyloid-beta (Abeta) peptides Abeta40 and Abeta42 are central events in the pathogenesis of Alzheimer disease. Previous studies have established the ratio of Abeta40 to Abeta42 as an important factor in determining the fibrillogenesis, toxicity, and pathological distribution of Abeta. To better understand the molecular basis underlying the pathologic consequences associated with alterations in the ratio of Abeta40 to Abeta42, we probed the concentration- and ratio-dependent interactions between well defined states of the two peptides at different stages of aggregation along the amyloid formation pathway. We report that monomeric Abeta40 alters the kinetic stability, solubility, and morphological properties of Abeta42 aggregates and prevents their conversion into mature fibrils. Abeta40, at approximately equimolar ratios (Abeta40/Abeta42 approximately 0.5-1), inhibits (> 50%) fibril formation by monomeric Abeta42, whereas inhibition of protofibrillar Abeta42 fibrillogenesis is achieved at lower, substoichiometric ratios (Abeta40/Abeta42 approximately 0.1). The inhibitory effect of Abeta40 on Abeta42 fibrillogenesis is reversed by the introduction of excess Abeta42 monomer. Additionally, monomeric Abeta42 and Abeta40 are constantly recycled and compete for binding to the ends of protofibrillar and fibrillar Abeta aggregates. Whereas the fibrillogenesis of both monomeric species can be seeded by fibrils composed of either peptide, Abeta42 protofibrils selectively seed the fibrillogenesis of monomeric Abeta42 but not monomeric Abeta40. Finally, we also show that the amyloidogenic propensities of different individual and mixed Abeta species correlates with their relative neuronal toxicities. These findings, which highlight specific points in the amyloid peptide equilibrium that are highly sensitive to the ratio of Abeta40 to Abeta42, carry important implications for the pathogenesis and current therapeutic strategies of Alzheimer disease.

摘要

淀粉样β蛋白(Aβ)肽Aβ40和Aβ42的聚集和纤维形成是阿尔茨海默病发病机制中的核心事件。先前的研究已确定Aβ40与Aβ42的比例是决定Aβ的纤维形成、毒性和病理分布的一个重要因素。为了更好地理解与Aβ40与Aβ42比例改变相关的病理后果的分子基础,我们探究了这两种肽在淀粉样形成途径中不同聚集阶段的明确状态之间的浓度和比例依赖性相互作用。我们报告称,单体Aβ40改变了Aβ42聚集体的动力学稳定性、溶解度和形态特性,并阻止其转化为成熟纤维。Aβ40以大约等摩尔比(Aβ40/Aβ42约为0.5 - 1)抑制(>50%)单体Aβ42的纤维形成,而以较低的亚化学计量比(Aβ40/Aβ42约为0.1)可抑制原纤维状Aβ42的纤维形成。通过引入过量的Aβ42单体可逆转Aβ40对Aβ42纤维形成的抑制作用。此外,单体Aβ42和Aβ40不断循环,并竞争结合到原纤维状和纤维状Aβ聚集体的末端。虽然两种单体物种的纤维形成都可以由由任何一种肽组成的纤维引发,但Aβ42原纤维选择性地引发单体Aβ42而非单体Aβ40的纤维形成。最后,我们还表明,不同个体和混合Aβ物种的淀粉样生成倾向与其相对神经元毒性相关。这些发现突出了淀粉样肽平衡中对Aβ40与Aβ42比例高度敏感的特定点,对阿尔茨海默病的发病机制和当前治疗策略具有重要意义。

相似文献

3
Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
Biomolecules. 2021 Jan 30;11(2):198. doi: 10.3390/biom11020198.
4
Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40.
J Biol Chem. 2005 Oct 14;280(41):35069-76. doi: 10.1074/jbc.M505763200. Epub 2005 Aug 3.
5
A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
J Struct Biol. 2016 Apr;194(1):61-7. doi: 10.1016/j.jsb.2016.01.013. Epub 2016 Jan 28.
6
Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species.
J Biol Chem. 2011 Mar 11;286(10):8585-8596. doi: 10.1074/jbc.M110.172411. Epub 2010 Dec 14.
8
Fibrillar amyloid peptides promote platelet aggregation through the coordinated action of ITAM- and ROS-dependent pathways.
J Thromb Haemost. 2020 Nov;18(11):3029-3042. doi: 10.1111/jth.15055. Epub 2020 Sep 13.
9
Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.
Arch Biochem Biophys. 2016 May 1;597:1-11. doi: 10.1016/j.abb.2016.03.017. Epub 2016 Mar 21.
10
Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation.
J Biol Chem. 2003 Jun 27;278(26):23648-55. doi: 10.1074/jbc.M212785200. Epub 2003 Apr 25.

引用本文的文献

1
Implications of Mucin-Type -Glycosylation in Alzheimer's Disease.
Molecules. 2025 Apr 24;30(9):1895. doi: 10.3390/molecules30091895.
2
Spectral Heterogeneity of Thioflavin T Binding to Aβ42:Aβ40 Mixed Fibrils: Implications for Alzheimer's Disease Screening.
ACS Omega. 2025 Apr 21;10(16):17043-17050. doi: 10.1021/acsomega.5c02756. eCollection 2025 Apr 29.
5
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression risk.
Alzheimers Dement. 2025 Feb;21(2):e14545. doi: 10.1002/alz.14545. Epub 2025 Jan 27.
6
The Aβ:Aβ ratio modulates aggregation in beta-amyloid oligomers and drives metabolic changes and cellular dysfunction.
Front Cell Neurosci. 2024 Dec 5;18:1516093. doi: 10.3389/fncel.2024.1516093. eCollection 2024.
8
Amyloid pathology and cognitive impairment in hAβ-KI and APP-KI mouse models of Alzheimer's disease.
Neurobiol Aging. 2025 Jan;145:13-23. doi: 10.1016/j.neurobiolaging.2024.10.005. Epub 2024 Oct 19.
10
Biofluid biomarkers for Alzheimer's disease.
Front Aging Neurosci. 2024 Apr 10;16:1380237. doi: 10.3389/fnagi.2024.1380237. eCollection 2024.

本文引用的文献

1
Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.
J Biol Chem. 2007 Aug 17;282(33):23818-28. doi: 10.1074/jbc.M701078200. Epub 2007 Jun 4.
2
Abeta40 protects non-toxic Abeta42 monomer from aggregation.
J Mol Biol. 2007 Jun 15;369(4):909-16. doi: 10.1016/j.jmb.2007.04.014. Epub 2007 Apr 12.
3
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.
J Neurochem. 2007 May;101(4):1053-9. doi: 10.1111/j.1471-4159.2006.04404.x. Epub 2007 Jan 24.
4
Polymorphism in the intermediates and products of amyloid assembly.
Curr Opin Struct Biol. 2007 Feb;17(1):48-57. doi: 10.1016/j.sbi.2007.01.007. Epub 2007 Jan 23.
5
Abeta40 inhibits amyloid deposition in vivo.
J Neurosci. 2007 Jan 17;27(3):627-33. doi: 10.1523/JNEUROSCI.4849-06.2007.
6
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies.
J Neural Transm (Vienna). 2006 Nov;113(11):1771-8. doi: 10.1007/s00702-006-0537-z. Epub 2006 Aug 17.
7
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.
Brain. 2006 May;129(Pt 5):1177-87. doi: 10.1093/brain/awl063. Epub 2006 Apr 6.
8
9
Thermodynamics of A beta(1-40) amyloid fibril elongation.
Biochemistry. 2005 Sep 27;44(38):12709-18. doi: 10.1021/bi050927h.
10
Molecular recycling within amyloid fibrils.
Nature. 2005 Jul 28;436(7050):554-8. doi: 10.1038/nature03986.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验